Extended release microparticle-in-gel formulation of octreotide: Effect of polymer type on acylation of peptide during in vitro release
- 1 December 2015
- journal article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 496 (2), 676-688
- https://doi.org/10.1016/j.ijpharm.2015.11.002
Abstract
No abstract availableKeywords
Funding Information
- National Health Institute (R01 EY 09171-14, R01 EY 10659-12)
This publication has 35 references indexed in Scilit:
- Poly-є-caprolactone based formulations for drug delivery and tissue engineering: A reviewJournal of Controlled Release, 2012
- Reversible Blocking of Amino Groups of Octreotide for the Inhibition of Formation of Acylated Peptide Impurities in Poly(Lactide-co-Glycolide) Delivery SystemsAAPS PharmSciTech, 2011
- Controlled Release of Octreotide and Assessment of Peptide Acylation from Poly(D,L-lactide-co-hydroxymethyl glycolide) Compared to PLGA MicrospheresPharmaceutical Research, 2011
- Medical Therapy of AcromegalyDrugs, 2009
- A new class of inhibitors of peptide sorption and acylation in PLGAJournal of Controlled Release, 2009
- Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditionsAAPS PharmSciTech, 2003
- The effect of poly(ethylene glycol)–poly(d,l-lactic acid) diblock copolymers on peptide acylationJournal of Controlled Release, 2002
- Clinical Pharmacokinetics of OctreotideClinical Pharmacokinetics, 1993
- Mechanisms of solute release from porous hydrophilic polymersInternational Journal of Pharmaceutics, 1983
- Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matricesJournal of Pharmaceutical Sciences, 1963